Chun-Mei Hu

11PUBLICATIONS
31CO-AUTHORS
Molecular targetsPharmacogenomicsMedical biochemistry - nucleic acidsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 03, 2025
Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee

|Mar 29, 2025
RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress.

Sui-Chih Tien, Mei Shih, Chun-Mei Hu

|Mar 22, 2025
Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee

|Dec 10, 2024
Investigation of pH-dependent 1H NMR urine metabolite profiles for diagnosis of obesity-related disordering.

Dan-Ni Wu, Erickson Fajiculay, Chao-Ping Hsu

|Oct 25, 2024
SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front.

Yi-Ing Chen, Sui-Chih Tien, Yi-Ling Ko

Pageof 2